Artwork for podcast Pathfinders in Biopharma
Ocular Therapeutix’ bold vision to redefine retinal disease treatment
Episode 36 • 3rd July 2025 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:24:51

Share Episode

Shownotes

Pravin Dugel, CEO of Ocular Therapeutix provides insights into existing treatments and future product candidates for retinal diseases, underlining the unique challenges, opportunities and innovations in this evolving landscape.

www.ocutx.com

Pravin U. Dugel, MD Biography

Follow

Links

Chapters

Video

More from YouTube